{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:14:10Z","timestamp":1766441650414},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Oncology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.oraloncology.2011.09.013","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T18:11:07Z","timestamp":1319739067000},"page":"10-17","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation"],"prefix":"10.1016","volume":"48","author":[{"given":"Jason D.","family":"Howard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oraloncology.2011.09.013_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","article-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","volume":"31","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0015","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0020","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/cncr.24760","article-title":"Annual report to the nation on the status of cancer, 1975\u20132006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates","volume":"116","author":"Edwards","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0035","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2010.07.179","article-title":"Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer","author":"Koutcher","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0065","unstructured":"Institute NC: Clinical Trials of FDA-Approved Drugs for Targeted Therapies."},{"key":"10.1016\/j.oraloncology.2011.09.013_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0075","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-06-0913","article-title":"Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting","volume":"12","author":"Sok","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hed.2880110510","article-title":"Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines","volume":"11","author":"Weichselbaum","year":"1989","journal-title":"Head Neck"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0085","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0095","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0100","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","article-title":"Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study","volume":"23","author":"Burtness","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0105","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1158\/1078-0432.CCR-08-0539","article-title":"Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer","volume":"14","author":"Hirsch","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/annonc\/mdq588","article-title":"Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and\/or metastatic squamous cell carcinoma of the head and neck: EXTREME study","volume":"22","author":"Licitra","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0115","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/13543784.17.10.1517","article-title":"EGFR inhibition as a therapy for head and neck squamous cell carcinoma","volume":"17","author":"Loeffler-Ragg","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0120","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1158\/1078-0432.CCR-10-3338","article-title":"Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment","volume":"17","author":"Tinhofer","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1758-3284-3-11","article-title":"The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"3","author":"Chau","year":"2011","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2009.03992.x","article-title":"Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy","volume":"158","author":"Martinelli","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0135","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00262-009-0697-4","article-title":"Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells","volume":"58","author":"Lopez-Albaitero","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0140","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hed.21365","article-title":"Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck","volume":"32","author":"Sharafinski","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12026-011-8231-0","article-title":"Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity","volume":"50","author":"Lee","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0150","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/onc.2008.19","article-title":"Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members","volume":"27","author":"Wheeler","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0155","doi-asserted-by":"crossref","first-page":"e12702","DOI":"10.1371\/journal.pone.0012702","article-title":"Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma","volume":"5","author":"Hatakeyama","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0160","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1038\/onc.2010.170","article-title":"Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity","volume":"29","author":"Basu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0165","article-title":"HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT","author":"Bruzzese","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0170","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1078-0432.CCR-05-2173","article-title":"PIK3CA mutations in head and neck squamous cell carcinoma","volume":"12","author":"Qiu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0175","first-page":"101","article-title":"Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas","volume":"32","author":"Murugan","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.1207","article-title":"Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma","volume":"198","author":"Woenckhaus","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0185","first-page":"1429","article-title":"PTEN expression and methylation status in oral squamous cell carcinoma","volume":"19","author":"Kurasawa","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0190","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<432::AID-IJC18>3.0.CO;2-#","article-title":"Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis","volume":"84","author":"Gasparotto","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0195","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1158\/1078-0432.CCR-07-1041","article-title":"Dissecting the Akt\/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative","volume":"13","author":"Molinolo","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1158\/1535-7163.MCT-10-0994","article-title":"PIK3CA mutations in patients with advanced cancers treated with PI3K\/AKT\/mTOR axis inhibitors","volume":"10","author":"Janku","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0205","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0215","doi-asserted-by":"crossref","first-page":"19503","DOI":"10.1073\/pnas.0905056106","article-title":"Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition","volume":"106","author":"Faber","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0220","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1158\/1078-0432.CCR-08-3252","article-title":"HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer","volume":"15","author":"Knowles","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0225","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1158\/0008-5472.CAN-08-2881","article-title":"The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma","volume":"69","author":"Seiwert","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0230","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10585-009-9280-9","article-title":"MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers","volume":"26","author":"Ghadjar","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0235","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa073770","article-title":"TP53 mutations and survival in squamous-cell carcinoma of the head and neck","volume":"357","author":"Poeta","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0240","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/path.1242","article-title":"Mutated p53 as a molecular marker for the diagnosis of head and neck cancer","volume":"198","author":"van Houten","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0245","first-page":"1188","article-title":"Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2\u201311 and human papillomavirus 16\/18 E6 transcripts in 123 unselected tumor specimens","volume":"63","author":"Balz","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0250","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1073\/pnas.96.13.7382","article-title":"Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array","volume":"96","author":"Ahrendt","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0255","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","article-title":"Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer","volume":"107","author":"Morton","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Suzuki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0265","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ccr.2009.03.003","article-title":"PRIMA-1 reactivates mutant p53 by covalent binding to the core domain","volume":"15","author":"Lambert","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2010.10.011","article-title":"P53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma","volume":"47","author":"Roh","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0275","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0696-682","article-title":"Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment","volume":"2","author":"Mao","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cyto.a.20504","article-title":"Losses of 3p14 and 9p21 as shown by fluorescence in situ hybridization are early events in tumorigenesis of oral squamous cell carcinoma and already occur in simple keratosis","volume":"73","author":"Schwarz","year":"2008","journal-title":"Cytometry A"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0285","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.22355","article-title":"Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer","volume":"120","author":"Reimers","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0290","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0002-9440(10)63871-0","article-title":"Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus","volume":"162","author":"Klussmann","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0295","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.oraloncology.2010.06.016","article-title":"Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma","volume":"46","author":"Brieger","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0300","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1038\/sj.onc.1202244","article-title":"Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2\u2019-deoxycytidine treatment induces a senescence-like state","volume":"17","author":"Timmermann","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0305","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/0008-5472.CAN-10-3184","article-title":"Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model","volume":"71","author":"Belinsky","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0310","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000232450","article-title":"Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor","volume":"55","author":"Shin","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0315","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massague","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0320","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0325","first-page":"1618","article-title":"Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2","volume":"7","author":"Muro-Cacho","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0330","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1158\/0008-5472.CAN-04-1032","article-title":"Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation","volume":"64","author":"Lu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0335","first-page":"1243","article-title":"Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma","volume":"5","author":"Muro-Cacho","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0340","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1158\/0008-5472.CAN-08-4623","article-title":"Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K\/Akt pathway","volume":"69","author":"Bian","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0345","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ejca.2010.02.040","article-title":"Targeting the transforming growth factor-beta signalling pathway in metastatic cancer","volume":"46","author":"Korpal","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0350","first-page":"205","article-title":"Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases","volume":"21","author":"Takayama","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0355","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-009-0267-2","article-title":"NF-kappaB and cancer: how intimate is this relationship","volume":"336","author":"Prasad","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0360","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1158\/0008-5472.CAN-10-3445","article-title":"{Delta}Np63 Versatilely Regulates a Broad NF-{kappa}B Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation","volume":"71","author":"Yang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0365","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/0008-5472.CAN-09-2613","article-title":"Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta","volume":"70","author":"Chatterjee","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0370","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/hed.20437","article-title":"High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma","volume":"28","author":"Bindhu","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0375","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1158\/0008-5472.CAN-06-1213","article-title":"Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma","volume":"66","author":"Chung","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0380","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1634\/theoncologist.11-1-51","article-title":"A practical update on the use of bortezomib in the management of multiple myeloma","volume":"11","author":"San Miguel","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0385","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/er.2006-0046","article-title":"Notch signaling in development and cancer","volume":"28","author":"Bolos","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0390","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)81193-9","article-title":"Nuclear access and action of notch in vivo","volume":"93","author":"Struhl","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0395","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/blood-2010-05-286351","article-title":"Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia","volume":"117","author":"Demarest","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0405","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09999","article-title":"A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia","volume":"473","author":"Klinakis","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0410","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng1099","article-title":"Notch1 functions as a tumor suppressor in mouse skin","volume":"33","author":"Nicolas","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0415","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrd3288","article-title":"Alzheimer\u2019s failure raises questions about disease-modifying strategies","volume":"9","author":"Extance","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0420","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.2007.12.7662","article-title":"EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer","volume":"26","author":"Kumar","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0425","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-10-1262","article-title":"Relationship between epidermal growth factor receptor status, p16INK4A and outcome in head and neck squamous cell carcinoma","author":"Young","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0430","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jnci\/djp017","article-title":"E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells","volume":"101","author":"Rampias","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0435","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/sj.onc.1209275","article-title":"Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus","volume":"25","author":"Smeets","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0440","doi-asserted-by":"crossref","first-page":"e4941","DOI":"10.1371\/journal.pone.0004941","article-title":"Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability","volume":"4","author":"Richards","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0445","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archoto.2009.159","article-title":"Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer","volume":"135","author":"Spanos","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0450","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/viro.2000.0584","article-title":"The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha","volume":"277","author":"Barnard","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.oraloncology.2011.09.013_b0455","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2009.06.026","article-title":"HPV-induced oropharyngeal cancer, immune response and response to therapy","volume":"288","author":"Vu","year":"2010","journal-title":"Cancer Lett"}],"container-title":["Oral Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837511008384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837511008384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T04:27:47Z","timestamp":1543465667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368837511008384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1368837511008384"],"URL":"https:\/\/doi.org\/10.1016\/j.oraloncology.2011.09.013","relation":{},"ISSN":["1368-8375"],"issn-type":[{"value":"1368-8375","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}